That would be a super profitable, market monopolising, FDA, TGA, EMA, Israel approved, fast growing, peer financial leading, just on proof of concept one trick pony! Just in case you were trying to mislead with your porkies again pigs.
The multiple shots on goal at the mega indications are progressing and they are not priced in at all. Don't be a hater pigs. You like to refer to the highly shorted list but you fail to mention most of that shorting occurred prior to Clinuvel achieving milestone FDA approval. Plus you have never explained why you must follow and post about CUV constantly, such a super profitable and cashed up company, when you don't post on all those other highly shorted stocks in the Shortman list which are often losing massive amounts of cash and don't have the approvals Clinuvel has. They would seem to be much higher risked despite having higher valuations than CUV and more deserving of your close attention?
All IMO DYOR
CUV Price at posting:
$16.29 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)